Phoreus Biotechnology, Inc. — Form D/A

Phoreus Biotechnology, Inc. of OLATHE, KS, a company, filed a Form D amendment with the SEC on 2019-12-30. The offering totals $1.1M, of which $550K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Xiomara Sinisterra-HunterDirectorPort Saint Lucie, FL
Christopher BrandtDirectorBaltimore, MD
Michael CoeDirectorPerry, KS
Michael CoeExecutive OfficerPerry, KS
Lynn RundleDirectorAbingdon, VA
Bradley HollidayDirectorKansas City, MO
Nathan SinghDirectorSaint Louis, MO
Matthew TomichDirectorSeattle, WA
Matthew TomichPromoterSeattle, WA
Matthew TomichRelated PersonSeattle, WA
Randall ToshDirectorOlathe, KS
Randall ToshExecutive OfficerOlathe, KS
Rajeet PannuDirectorNew York, NY
Rajeet PannuPromoterNew York, NY
Rajeet PannuRelated PersonNew York, NY
David SchaeferDirectorClearwater Beach, FL
David SchaeferExecutive OfficerClearwater Beach, FL
David SchaeferPromoterClearwater Beach, FL
David SchaeferRelated PersonClearwater Beach, FL
Bill AshleyDirectorOverland Park, KS
Bill AshleyPromoterOverland Park, KS
Bill AshleyRelated PersonOverland Park, KS
Steve SchramDirectorGoodyear, AZ
Steve SchramPromoterGoodyear, AZ
Steve SchramRelated PersonGoodyear, AZ

Other filings by this issuer (6)

FiledFormOfferingSold
2026-03-13D$421K
2026-03-13D/A$4.4M
2022-05-11D/A$3.0M$1.9M
2020-05-26D$2.0M
2019-07-19D/A$1.1M$300K
2018-08-02D$1.0M$50K

More